Sangamo Therapeutics
SGMO
#10606
Rank
S$39.16 M
Marketcap
S$0.09454
Share price
0.00%
Change (1 day)
-87.88%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -S$0.15 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are S$34.55 Million. In 2025 the company made an earning of -S$0.14 Billion a decrease over its 2024 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.15 Billion2.65%
2025 -S$0.14 Billion9.71%
2024 -S$0.13 Billion-17.27%
2023 -S$0.16 Billion-40.88%
2022 -S$0.26 Billion9.79%
2021 -S$0.24 Billion41.52%
2020 -S$0.17 Billion23.17%
2019 -S$0.14 Billion36.33%
2018 -S$98.57 Million36.89%
2017 -S$72.01 Million-22.32%
2016 -S$92.71 Million54.86%
2015 -S$59.87 Million75.62%
2014 -S$34.09 Million0.13%
2013 -S$34.05 Million
2011 -S$45.77 Million43.66%
2010 -S$31.86 Million28.52%
2009 -S$24.79 Million-23.55%
2008 -S$32.43 Million2.45%
2007 -S$31.65 Million19.5%
2006 -S$26.49 Million50.78%
2005 -S$17.57 Million75%
2004 -S$10.04 Million-33.25%
2003 -S$15.04 Million-62.27%
2002 -S$39.86 Million102.82%
2001 -S$19.65 Million23.21%
2000 -S$15.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.48 B-23,855.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$13.14 B-9,424.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$1.29 B-1,016.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-S$1.28 Billion 803.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-S$2.5 Billion 1,672.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.82 B-7,070.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.43 B-1,119.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.19 B-235.16%๐Ÿ‡บ๐Ÿ‡ธ USA